Handel nachbörslich: 1.99

Incannex Healthcare Inc (IXHL)

Incannex Healthcare Inc Aktie (IXHL) Neueste Nachrichten

Incannex Healthcare Inc (IXHL)

Incannex Healthcare Inc Aktie (IXHL) Neueste Nachrichten

Incannex Healthcare Inc. (NASDAQ:IXHL) Sees Significant Growth in Short Interest - Defense World

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates - The Manila Times

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates - GlobeNewswire

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates - StockTitan

Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Update - MarketBeat

Incannex Secures Up to $60M in Financing to Support Clinical Trials - Sleep Review

Incannex secures financing deal valued at US$60 million - Mugglehead

Incannex $60 Million Deal With Arena For Late-Stage Drug TrialsIncannex Healthcare (NASDAQ:IXHL) - Benzinga

Incannex Healthcare secures $60 million funding via equity and debt - Investing.com

Incannex Healthcare secures $60 million funding via equity and debt By Investing.com - Investing.com UK

Incannex Healthcare lands $60 million financing deal - Green Market Report

Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors - GlobeNewswire

Incannex secures $60 million in funding for clinical trials - Investing.com

Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors - StockTitan

Incannex Healthcare Inc. (NASDAQ:IXHL) Sees Large Growth in Short Interest - MarketBeat

Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Update - Defense World

Thinking about buying stock in Altimmune, UiPath, Incannex Healt - GuruFocus.com

Virtu Financial LLC Buys New Shares in Incannex Healthcare Inc. (NASDAQ:IXHL) - Defense World

4 Psychedelic Stocks to Consider as Clinical Trials Heat up - Investing.com

FDA Review of PsiGAD2 IND complete; clinical trial for - GlobeNewswire

FDA Clears Incannex To Proceed With Phase 2 Psilocybin-Assisted Therapy Trial For Anxiety - Benzinga

Incannex Healthcare gets FDA nod for Phase 2 trial - Green Market Report

FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed - StockTitan

Tidal Investments LLC Buys New Stake in Incannex Healthcare Inc. (NASDAQ:IXHL) - MarketBeat

Tidal Investments LLC Acquires Shares of 423,410 Incannex Healthcare Inc. (NASDAQ:IXHL) - Defense World

Dosing completed in 115 participant - GlobeNewswire

Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X - Yahoo Finance

Head to Head Review: Zai Lab (NASDAQ:ZLAB) vs. Incannex Healthcare (NASDAQ:IXHL) - Defense World

Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Down 69.0% in June - MarketBeat

7 Best Psychedelic Stocks in 2024 | Investing - U.S News & World Report Money

Patient Dosing Begins in Phase 2/3 Trial for OSA Drug Candidate IHL-42X - Sleep Review

Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea - GlobeNewswire Inc.

Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea - Yahoo Finance

Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder - GlobeNewswire Inc.

Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder - Yahoo Finance

'Truly Remarkable’ Results Spur Incannex's Phase 2/3 Trials for Sleep Apnea Drug Candidate, Says CEO - Sleep Review

Incannex prepares IND submission for psychotherapy asset - Pharmaceutical Technology

symbol__ Stock Quote Price and Forecast - CNN

11 Best ASX Stocks To Buy Now - Yahoo Finance

Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado - Quantisnow

Pα+ Psychedelic Bulletin #157: Psilocybin for Generalised Anxiety Disorder; Uptick in Psilocybin-Related Poison ... - Psychedelic Alpha

Incannex’s Psilocybin Clears Phase II Trial in Generalized Anxiety Disorder - BioSpace

Incannex Announces Positive Topline Results from Phase 2 - GlobeNewswire

How to buy Incannex Healthcare (IHL) shares in Australia - finder.com.au

Why Incannex Healthcare's (NASDAQ:IXHL) Earnings Are Weaker Than They Seem - Simply Wall St

Cannabis stocks eye US Federal legalisation after difficult year - Proactive Investors Australia

Incannex advances smoking cessation gum in FDA meeting By Investing.com - Investing.com Australia

Incannex Healthcare targeting $120 billion global addressable market with cannabinoid and psychedelic therapeutics - Proactive Investors Australia

Is Incannex Healthcare (NASDAQ:IXHL) In A Good Position To Invest In Growth? - Simply Wall St

Incannex and partner Clarion open Australia’s first psychedelic therapy clinic in Melbourne - Mugglehead

Incannex Healthcare Inc Share PriceIXHL, RNS News, Articles, Quotes, & Charts (NASDAQ:IXHL) - Proactive Investors UK

Incannex Healthcare Inc Share PriceIXHL, RNS News, Articles, Quotes, & Charts (NASDAQ:IXHL) - Proactive Investors Australia

Incannex begins dosing in Phase II rheumatoid arthritis drug trial - Clinical Trials Arena

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis - Yahoo Finance

Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted ... - Yahoo Finance

Incannex Gets IRB Approval to Start Phase 2/3 Trial of OSA Drug Candidate IHL-42X - Sleep Review

Incannex Receives IRB Approval for the RePOSA Phase 2/3 - GlobeNewswire

Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia - Yahoo Finance

Initiation of Phase 2/3 Trial Underway for OSA Drug Candidate IHL-42X - Sleep Review

Merit Medical Systems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

These 3 Biotech Stocks More Than Doubled in November. Can They Fly Even Higher in 2024? - The Motley Fool

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.82% - Investing.com India

U.S. shares mixed at close of trade; Dow Jones Industrial Average up 1.47% - Investing.com India

Incannex Healthcare Announces Completion of its Redomiciliation to the United States - Yahoo Finance

Incannex Healthcare to appoint Computershare as Nasdaq transfer agent/registrar - Proactive Investors Australia

Federal Court of Australia Approves Incannex’s Re-Domiciliation and Lodgement of Court Orders With ASIC - Yahoo Finance

Incannex Healthcare shareholders vote in favour of exclusive Nasdaq listing - Small Caps

Ähnlich wie IXHL